Financial Ratios

ZOTA HEALTH CARE LTD.

NSE : ZOTABSE : ISIN CODE : INE358U01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE486.40-6.1 (-1.24 %)
PREV CLOSE( ) 492.50
OPEN PRICE ( ) 488.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 486.40 (201)
VOLUME 6971
TODAY'S LOW / HIGH( ) 484.00 495.10
52 WK LOW / HIGH ( )271.95 555
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)2.624.21-0.071.123.16
   CEPS(Rs)3.585.291.221.982.83
   DPS(Rs)1.001.501.001.001.00
   Book NAV/Share(Rs)37.5436.3227.0228.0339.29
   Tax Rate(%)23.5325.4548.5128.8729.36
Margin Ratios
   Core EBITDA Margin(%)5.3111.400.594.769.05
   EBIT Margin(%)6.2810.84-0.194.159.22
   Pre Tax Margin(%)6.2310.79-0.304.089.18
   PAT Margin (%)4.778.04-0.152.906.48
   Cash Profit Margin (%)6.5110.122.815.118.11
Performance Ratios
   ROA(%)5.2810.04-0.193.106.12
   ROE(%)7.1013.41-0.244.018.01
   ROCE(%)9.3518.09-0.305.7311.39
   Asset Turnover(x)1.111.251.231.070.94
   Sales/Fixed Asset(x)4.354.313.693.934.38
   Working Capital/Sales(x)2.363.112.492.372.01
Efficiency Ratios
   Fixed Capital/Sales(x)0.230.230.270.250.23
   Receivable days108.0093.1899.0498.3095.96
   Inventory Days84.1777.8591.33111.01121.05
   Payable days89.2070.6876.0885.76104.47
Valuation Parameters
   PER(x)107.5170.770.00115.9058.62
   PCE(x)78.6556.25113.2265.8665.59
   Price/Book(x)7.508.195.134.656.61
   Yield(%)0.350.500.720.770.39
   EV/Net Sales(x)5.125.683.173.365.30
   EV/Core EBITDA(x)67.0043.93175.3552.7848.86
   EV/EBIT(x)81.5152.34-1647.2380.8257.49
   EV/CE(x)5.685.963.963.615.07
   M Cap / Sales5.125.693.183.365.32
Growth Ratio
   Net Sales Growth(%)5.1823.1212.3111.0710.00
   Core EBITDA Growth(%)-37.82779.53-68.04-34.91-25.20
   EBIT Growth(%)-39.117034.71-105.21-49.98-31.12
   PAT Growth(%)-37.686614.84-105.88-50.29-23.61
   EPS Growth(%)-37.686459.48-105.88-64.49-23.61
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)3.002.293.363.163.15
   Quick Ratio(x)1.781.441.811.801.51
   Interest Cover(x)137.22194.87-1.8857.15214.57
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.